Royalty Pharma plc (RPRX): Weighted Average Diluted Shares
564.46M
Year ended 2025-12-31
+8.8%
3-year compound annual growth
+8.5%
5-year compound annual growth
| Period ended | Weighted Average Diluted Shares | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | 564.46M | -5.0% | 2026-02-11, From 2025-01-01 |
| 2024-12-31 | 594.11M | -1.5% | 2026-02-11, From 2024-01-01 |
| 2023-12-31 | 602.90M | +37.7% | 2026-02-11, From 2023-01-01 |
| 2022-12-31 | 437.97M | +5.6% | 2025-02-12, From 2022-01-01 |
| 2021-12-31 | 414.80M | +10.5% | 2024-02-15, From 2021-01-01 |
| 2020-12-31 | 375.45M | n/a | 2023-02-15, From 2020-01-01 |